Aztreonam
Back to searchMolecule Structure
Scientific Name
Aztreonam
Description of the Drug
Aztreonam is a beta-lactam antibiotic used to treat select aztreonam sensitive gram negative bacteria.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00355
http://www.drugbank.ca/drugs/DB00355
Brand Name(s)
Azactam, Aztreonam, Cayston
Company Owner(s)
Fresenius Kabi Usa Llc, Bristol Myers Squibb Co, Bristol Myers Squibb, Hospira Inc, Gilead Sciences Inc, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL37511 | ||
| Human Metabolome Database | HMDB0014499 | ||
| DrugBank | DB00355 | ||
| PubChem: Thomson Pharma | 14930214 | 14783375 | |
| PubChem | 5742832 | 135398736 | |
| Nikkaji | J306.677K | J20.598B | |
| BindingDB | 50240480 | ||
| DrugCentral | 279 | ||
| Brenda | 1487 | ||
| ChemicalBook | CB0386184 | ||
| Guide to Pharmacology | 10763 | ||
| rxnorm | AZTREONAM | CAYSTON | AZACTAM |
| PubChem: Drugs of the Future | 12013309 | ||
| ChEBI | 161680 | ||
| ZINC | ZINC000003830264 |
